:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Changfa Zhang, Shuai Li, Likang Li, Ruoting Wang, Shiming Luo, Guowei Li
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Endocrinology, Diabetes & Metabolism
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1002/edm2.482
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose Sensors
di: Vendula Navrátilová, et al.
Pubblicazione: (2025)

High‐Protein Diet Exacerbates Insulin Resistance via the JNK / IKKβ ‐ IRS ‐1 Pathway
di: Junjun Li, et al.
Pubblicazione: (2025)

Triglyceride‐Glucose Index Association With Severity of Coronary Artery Disease
di: Sara Saffar Soflaei, et al.
Pubblicazione: (2025)

Preliminary Outcomes of a Brief Values‐Guided Self‐Management Intervention to Improve Glucose Levels Among Emerging Adults With Type 1 Diabetes and Above‐Recommended HbA 1c : A Pilot Study
di: Sara E. Styles, et al.
Pubblicazione: (2026)

Age‐Dependent Effects of Muscle Resting Calcium on Fasting Blood Glucose: Implications for Prediabetes Risk
di: Eshwar R. Tammineni, et al.
Pubblicazione: (2025)

Lost in Transcription: Frequency of Inaccurate Manually Documented Point‐of‐Care Blood Glucose and Ketone Measures in Hospital
di: Ali Hazara, et al.
Pubblicazione: (2026)

Relationship Between Body Composition With Carotid Intima Media Thickness in Young Adults: Tehran Lipid and Glucose Study
di: Mohammad Nikoohemmat, et al.
Pubblicazione: (2026)

Association of Three Novel Inflammatory Markers: Lymphocyte to HDL‐C Ratio, High‐Sensitivity C‐Reactive Protein to HDL‐C Ratio and High‐Sensitivity C‐Reactive Protein to Lymphocyte Ratio With Metabolic Syndrome
di: Rana Kolahi Ahari, et al.
Pubblicazione: (2024)

Exploring Combined Use of Continuous Glucose Monitoring and Anti‐Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin
di: Poorva M. Nemlekar, et al.
Pubblicazione: (2025)

Association Between Impaired Fasting Glucose and Adverse Outcomes in Patients Treated With Peritoneal Dialysis: A Retrospective Study From Southern China
di: Qinghua Hu, et al.
Pubblicazione: (2026)

Renal Protection at a Metabolic Cost: A Systematic Review and Meta‐Analysis of Perioperative Use of Sodium–Glucose Cotransporter 2 Inhibitors
di: Elsayed Balbaa, et al.
Pubblicazione: (2026)

Association Between Hepatic Steatosis and Deterioration of Metabolic Health in Obese Individuals: A 12‐Year Follow‐Up of the Tehran Lipid and Glucose Study
di: Behnaz Abiri, et al.
Pubblicazione: (2026)

Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy
di: Maharan Kabha, et al.
Pubblicazione: (2025)

Interaction and Joint Effects of Inflammation and Triglyceride–Glucose ( TyG ) Index on Hyperuricemia Risk and the Mediating Role of TyG : A Cross‐Sectional Study
di: Xueran Huang, et al.
Pubblicazione: (2026)

Adipokine Levels and Glucose Metabolism Responses to the Acute Effects of High‐Intensity Interval Exercise (HIIE) and Moderate Intensity Continuous Exercise (MICE) in Prediabetic Obese Men
di: Hadi Golpasandi, et al.
Pubblicazione: (2025)

Hepato‐Renal Protective Potential of Dimethyl Fumarate in Alloxan‐Induced Diabetic Mice Model by Modulating of Sirt1, Nrf2 and Inflammatory Genes Expressions
di: Parisa Saberi‐Hasanabadi, et al.
Pubblicazione: (2026)

The Role of Serum Free Fatty Acids in Endothelium‐Dependent Microvascular Function
di: Alexander E. Sullivan, et al.
Pubblicazione: (2025)

Investigating the Relationship Between Serum Uric Acid and Dyslipidemia in Young Adults in Bangladesh
di: Abu Taher, et al.
Pubblicazione: (2025)

The Response of Alpha‐Aminoadipic Acid (2‐AAA) to Short Term Lysine Ingestion in Healthy Individuals
di: E. Danielle Dean, et al.
Pubblicazione: (2026)

Evaluation of the Relationship Between Serum Uric Acid and Cardiovascular Disease: A Cross‐Sectional Study in Bangladesh
di: Nurshad Ali, et al.
Pubblicazione: (2025)

Plasma Fatty Acid Profiles Modulate PPARγ Expression in Adipose Tissue: A Lipidomic Insight Into Obesity‐Related Metabolic Dysregulation
di: Maryam Sanoie, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitors‐Induced Endocrinopathies: Assessment, Management and Monitoring in a Comprehensive Cancer Centre
di: Omayma Elshafie, et al.
Pubblicazione: (2024)

Association Between the Triglycerides‐to‐High‐Density Lipoprotein‐Cholesterol ( TG / HDL ‐C) Ratio and Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Observational Studies
di: Mansour Bahardoust, et al.
Pubblicazione: (2026)

Preterm Birth Increases Susceptibility to Hyperglycemia‐Induced Kidney Injury With Sex‐Specific Differences in Structural and Molecular Responses
di: Rachel K. Dailey, et al.
Pubblicazione: (2026)

Associations Between Serum IL‐17A, Renal Function and Diabetic Retinopathy in Type 2 Diabetes Mellitus: Evidence From a Chinese Han Population
di: Wensu Wang, et al.
Pubblicazione: (2025)

Cushing's Syndrome in Pregnancy Secondary to Adrenocortical Adenoma: A Case Series and Review
di: Yan Wang, et al.
Pubblicazione: (2024)

Therapeutic Potential of Holothuria leucospilota Extract in STZ ‐Induced Diabetic Rats: Targeting Inflammation and Apoptosis at the Gene Expression Level
di: Niloufar Darbandi, et al.
Pubblicazione: (2026)

Effects of Empagliflozin‐Induced Glycosuria on Weight Gain, Food Intake and Metabolic Indicators in Mice Fed a High‐Fat Diet
di: Anh T. Nguyen, et al.
Pubblicazione: (2024)

Diabetic Kidney Disease Progression Alleviated in Mice by ALKBH5‐Mediated UC‐MSCs‐Derived Exosomes That Inhibit TRAF6 m6A Modification and Promote M2 Macrophage Polarisation
di: Lei Li, et al.
Pubblicazione: (2026)

Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
di: Yuanjie Mao, et al.
Pubblicazione: (2024)

Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening
di: George J. Kahaly, et al.
Pubblicazione: (2025)

Irisin, the Myokine: Guardian and Mediator in Cardiovascular System
di: Tian Lan, et al.
Pubblicazione: (2025)

Effects of GLP‐1 Receptor Agonists on Paediatric Population in a Real World Setting
di: A. G. Barajas, et al.
Pubblicazione: (2025)

Are Bifidobacterium Species Key Players in the Progression of Type 1 Diabetes? A Systematic Review
di: Vanina Vergoz, et al.
Pubblicazione: (2025)

Reevaluating the Need for Routine IGF ‐1 Screening in Poorly Controlled Type 2 Diabetes Mellitus
di: Munire Topalak Sonmez, et al.
Pubblicazione: (2026)

Association Between Serum Syndecan 1 Levels and Metabolic Syndrome Parameters: A Comparative Cross‐Sectional Study
di: Shima Tavalaie, et al.
Pubblicazione: (2025)

CAMKK1 in Obesity and Type 2 Diabetes Mellitus: Evidence of Interaction With Appetite‐Regulating, Metabolic and Inflammatory Factors
di: Livio Tarchi, et al.
Pubblicazione: (2025)

Predicting Time in Range Without Hypoglycaemia Using a Risk Calculator for Intermittently Scanned CGM in Type 1 Diabetes
di: Fernando Sebastian‐Valles, et al.
Pubblicazione: (2024)

Efficacy and Safety of Glucagon‐Like Peptide‐1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta‐Analysis
di: Abdur Rafay Bilal, et al.
Pubblicazione: (2026)

Correction to ‘Efficacy and Safety of iLet Bionic Pancreas in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta‐Analysis’
Pubblicazione: (2026)